Halt Medical announced that the American Medical Association (AMA) Current Procedure Terminology (CPT) Panel has established a new CPT® code specifically for Radiofrequency (RF) Ablation of Uterine Fibroids.
CPT codes used by medical practitioners; including physicians, hospitals, and others healthcare providers to report healthcare services to insurers for the purpose of reimbursement. This standardized nationwide system of identification provides a uniform language for reporting medical services.
"The existence of this unique code will simplify the process, for both providers and insurers, of submitting and processing claims on behalf of their patients," according to Russ DeLonzor, President and COO of Halt Medical, Inc. Jeffrey M. Cohen, CEO of Halt Medical added that, "Category III CPT Codes are reserved for important new and emerging technologies, such as the Acessa™ Procedure, and are intended to recognize and capture reported services and procedures. As a healthcare manufacturing company, we are incredibly pleased with this development. We look forward to working with our customers and insurers to continue improving access to this procedure for those women suffering from symptomatic uterine fibroids."
The Acessa Procedure is a minimally invasive laparoscopic procedure that delivers radiofrequency energy to destroy the fibroids. After treatment, the fibroid is re-absorbed by the surrounding tissue. Acessa allows the surgeon to treat only the fibroids, while preserving normal function of the uterus. Patients typically go home the same day with little pain, and enjoy a rapid return to normal activities. More than 300 women have been successfully treated with Acessa.
CPT codes used by medical practitioners; including physicians, hospitals, and others healthcare providers to report healthcare services to insurers for the purpose of reimbursement. This standardized nationwide system of identification provides a uniform language for reporting medical services.
"The existence of this unique code will simplify the process, for both providers and insurers, of submitting and processing claims on behalf of their patients," according to Russ DeLonzor, President and COO of Halt Medical, Inc. Jeffrey M. Cohen, CEO of Halt Medical added that, "Category III CPT Codes are reserved for important new and emerging technologies, such as the Acessa™ Procedure, and are intended to recognize and capture reported services and procedures. As a healthcare manufacturing company, we are incredibly pleased with this development. We look forward to working with our customers and insurers to continue improving access to this procedure for those women suffering from symptomatic uterine fibroids."
The Acessa Procedure is a minimally invasive laparoscopic procedure that delivers radiofrequency energy to destroy the fibroids. After treatment, the fibroid is re-absorbed by the surrounding tissue. Acessa allows the surgeon to treat only the fibroids, while preserving normal function of the uterus. Patients typically go home the same day with little pain, and enjoy a rapid return to normal activities. More than 300 women have been successfully treated with Acessa.
No comments:
Post a Comment